Puerto Rican Alzheimer’s Patients To Be First In U.S. To Obtain Cannabis-Based Relief

indoor grow

MARYLAND: Alzheimer’s patients in Puerto Rico will be the first in the United States to obtain Hyalolex, IGC’s proprietary cannabinoid based formulation aimed at relieving many of the symptoms of Alzheimer’s Disease, such as agitation, anxiety, sleep disorder, as well as caregiver distress, among others. Pursuant to an agreement between IGC and DaMa Pharmaceutical and its Read the full article…